Elegen

Elegen

Private
San Carlos, CaliforniaHealthcare & Life Scienceshttps://www.elegenbio.com

Last Round

Series B

May 14, 2024

Est. Valuation

$100M

Total Funding Raised

$36.21M

Company Overview

Elegen is a biotechnology company specializing in microfluidics technology that aims to revolutionize synthetic biology through genome engineering and rapid DNA synthesizer development to enhance biomedical progress and DNA sequence testing in healthcare.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

synthetic DNADNA synthesiscell-free DNA synthesisgene synthesisDNA printinglong DNA synthesisplasmid DNAgenetic medicinescell and gene therapysynthetic biologyDNA as a ServicemRNA synthesislinear DNAIVT ready DNANGS verification

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Elegen Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Elegen Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BMay 14, 2024
GrantSep 23, 2020

Elegen Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Dr. Marc Unger, inventor of the Nanoflex valve, joins as an advisor.

  • Jul 15, 2025

    Joint pilot program with Nutcracker Therapeutics for RNA-based therapeutics.

Elegen Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Elegen Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Elegen's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Carlos, California
Employee Range82
Year Founded2017
Last FundingMay 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.